BrightSpring Health Services, Inc. (BTSG)
(Delayed Data from NSDQ)
$19.64 USD
-1.01 (-4.89%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $19.62 -0.02 (-0.10%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
BTSG 19.64 -1.01(-4.89%)
Will BTSG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BTSG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BTSG
BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates
5 Broker-Loved Stocks to Monitor Closely Amid Volatility
BTSG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy?
BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy?
Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year?
Other News for BTSG
Beyond the Balance Sheet: What SWOT Reveals About BrightSpring Health Services Inc (BTSG)
BrightSpring Health Services Inc (BTSG) Q2 2025 Earnings Call Highlights: Robust Revenue Growth ...
Q2 2025 Brightspring Health Services Inc Earnings Call Transcript
BrightSpring raises 2025 adjusted EBITDA guidance to $605M while expanding specialty pharmacy and infusion growth
BrightSpring Health Services, Inc. (BTSG) Q2 2025 Earnings Call Transcript